Cognitive impairment in heart failure: clinical implications, tools of assessment, and therapeutic considerations Sotiria LioriAngelos Arfaras-MelainisJohn Parissis ReviewPaper 03 May 2021 Pages: 993 - 999
Social and environmental risks as contributors to the clinical course of heart failure Koichi NaritaEisuke Amiya ReviewPaper 04 May 2021 Pages: 1001 - 1016
Sedentary behavior and health outcomes in patients with heart failure: a systematic review and meta-analysis Qiuge ZhaoCancan ChenXiuzhen Fan ReviewPaper 22 June 2021 Pages: 1017 - 1028
Efficacy of motivational interviewing on enhancing self-care behaviors among patients with chronic heart failure: a systematic review and meta-analysis of randomized controlled trials Greta GhizzardiCristina ArrigoniRosario Caruso ReviewPaper 17 April 2021 Pages: 1029 - 1041
Dependence and reduced motor function in heart failure: future directions for well-being Hidetaka HibinoStacey L. Gorniak ReviewPaper 24 July 2021 Pages: 1043 - 1051
Minimally invasive versus conventional continuous-flow left ventricular assist device implantation for heart failure: a meta-analysis Bufan ZhangShaohua GuoZhigang Liu ReviewPaper 03 April 2021 Pages: 1053 - 1061
Ventricular non-compaction review Shaurya SrivastavaMajid YavariGeorge Abela ReviewPaper 07 July 2021 Pages: 1063 - 1076
Right ventricular diastolic dysfunction and failure: a review Youn-Hoa JungXianfeng RenWei Dong Gao ReviewPaper 19 May 2021 Pages: 1077 - 1090
Subclinical cardiac damage in cancer patients before chemotherapy Iacopo FabianiGiorgia PanichellaAlberto Giannoni ReviewPaper Open access 27 July 2021 Pages: 1091 - 1104
Risk stratification in cardiogenic shock: a focus on the available evidence C. SciaccalugaG. E. MandoliM. Cameli ReviewPaper Open access 14 July 2021 Pages: 1105 - 1117
Current and emerging drug targets in heart failure treatment Nicolò GhionzoliFrancesco GentileGiuseppe Vergaro ReviewPaper Open access 17 July 2021 Pages: 1119 - 1136
New antidiabetic therapy and HFpEF: light at the end of tunnel? Marijana TadicCarla SalaCesare Cuspidi ReviewPaper Open access 11 April 2021 Pages: 1137 - 1146
Paradigm shift in heart failure treatment: are cardiologists ready to use gliflozins? Michele CorrealeRenata PetroniSavina Nodari ReviewPaper 07 June 2021 Pages: 1147 - 1163
The place of vericiguat in the landscape of treatment for heart failure with reduced ejection fraction Alberto AimoVincenzo CastiglioneMichele Emdin ReviewPaper Open access 21 July 2021 Pages: 1165 - 1171
Dilated cardiomyopathy in the era of precision medicine: latest concepts and developments Nicoletta OrphanouEfstathios PapatheodorouAris Anastasakis ReviewPaper 14 July 2021 Pages: 1173 - 1191
Transcatheter therapies for secondary mitral regurgitation in advanced heart failure: what are we aiming for? Andrea ScottiAndrea MunafòCosmo Godino ReviewPaper Open access 22 July 2021 Pages: 1193 - 1200
Heart failure and atrial fibrillation: new concepts in pathophysiology, management, and future directions Grigorios TsigkasAnastasios ApostolosPeriklis Davlouros ReviewPaper 04 July 2021 Pages: 1201 - 1210
Exosomes in atrial fibrillation: therapeutic potential and role as clinical biomarkers Kun XiangMuhammad AkramChengming Fan ReviewPaper 12 July 2021 Pages: 1211 - 1221
Diagnosis of cardiac sarcoidosis: a primer for non-imagers Tanushree AgrawalYehia SalehMouaz Al-Mallah ReviewPaper 29 June 2021 Pages: 1223 - 1233
The role of non-invasive imaging modalities in cardiac allograft vasculopathy: an updated focus on current evidences C SciaccalugaN GhionzoliM Cameli ReviewPaper Open access 12 August 2021 Pages: 1235 - 1246
Speckle tracking echocardiography in primary mitral regurgitation: should we reconsider the time for intervention? Maria Concetta PastoreGiulia Elena MandoliMatteo Cameli ReviewPaper Open access 07 April 2021 Pages: 1247 - 1260
The non-invasive assessment of myocardial work by pressure-strain analysis: clinical applications Dawud AbawiTommaso RinaldiAlessio Alogna ReviewPaper Open access 26 May 2021 Pages: 1261 - 1279
Remote monitoring for heart failure using implantable devices: a systematic review, meta-analysis, and meta-regression of randomized controlled trials Alexander G. HajduczokSamer N. MuallemJohn P. Boehmer ReviewPaper 24 September 2021 Pages: 1281 - 1300
Functional tricuspid regurgitation, related right heart remodeling, and available treatment options: good news for patients with heart failure? Marijana TadicCesare CuspidiWolfang Rottbauer ReviewPaper Open access 15 July 2021 Pages: 1301 - 1312
Deciphering hypertrophic cardiomyopathy with electrocardiography Thomas GossiosKonstantinos SavvatisGeorgios K. Efthimiadis ReviewPaper 21 July 2021 Pages: 1313 - 1323
Heart–lung interactions in COVID-19: prognostic impact and usefulness of bedside echocardiography for monitoring of the right ventricle involvement Michael Dandel ReviewPaper 17 April 2021 Pages: 1325 - 1339
Clinical variants of myocardial involvement in COVID-19-positive patients: a cumulative experience of 2020 Maya GuglinKareem BallutRoopa Rao ReviewPaper 02 July 2021 Pages: 1341 - 1353
Filamin C in cardiomyopathy: from physiological roles to DNA variants Shen SongAnteng ShiYu Nie ReviewPaper 17 September 2021 Pages: 1373 - 1385
Mitochondrial abnormalities: a hub in metabolic syndrome-related cardiac dysfunction caused by oxidative stress Aoxue LiNingning ZhengXudong Ding ReviewPaper Open access 05 May 2021 Pages: 1387 - 1394
Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases Mieczysław DutkaRafał BobińskiKarolina Zimmer ReviewPaper Open access 27 July 2021 Pages: 1395 - 1411
Multiple roles of cardiac macrophages in heart homeostasis and failure Aneta MoskalikJustyna Niderla-BielińskaAnna Ratajska ReviewPaper Open access 13 August 2021 Pages: 1413 - 1430
New insights into the roles of glucocorticoid signaling dysregulation in pathological cardiac hypertrophy Jingmin YangYanying ChenDanyan Xu ReviewPaper 28 August 2021 Pages: 1431 - 1441
A deep dive into the darning effects of biomaterials in infarct myocardium: current advances and future perspectives Thiagarajan HemalathaMayilvahanan AarthyNiraikulam Ayyadurai ReviewPaper 03 August 2021 Pages: 1443 - 1467
Response to letter to the editor regarding the article “SGLT2 inhibitors and cardiovascular and renal outcomes: a meta-analysis and trial sequential analysis” Cardiac, renal protection with SGLT2 inhibitors is evident but not in every diabetic patient Mahmoud BarbarawiOwais BarbarawiKai Chen Letter 04 May 2021 Pages: 1469 - 1469